Back
Innate Pharma SA Stock Price Chart
Sponsored
IPHA
Sponsored
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
16
IPHA
Innate Pharma SA
Last Price:
2.16
Seasonality Move:
-22.97%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing slight buying pressure.
Innate Pharma SA Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.25 | Sell |
20-day SMA: | 2.27 | Sell |
50-day SMA: | 2.23 | Buy |
200-day SMA: | 2.46 | Sell |
8-day EMA: | 2.25 | Sell |
20-day EMA: | 2.26 | Sell |
50-day EMA: | 2.26 | Sell |
200-day EMA: | 2.43 | Sell |
Innate Pharma SA Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 49.51 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.21 - 2.33) | Sell |
Bollinger Bands (100): | (2.08 - 2.6) | Sell |
Innate Pharma SA Technical Analysis
Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Innate Pharma SA Stock
Is Innate Pharma SA Stock a Buy?
- Innate Pharma SA share price is 2.25 while IPHA 8-day simple moving average is 2.25, which is a Sell signal.
- The stock price of IPHA is 2.25 while Innate Pharma SA 20-day SMA is 2.27, which makes it a Sell.
- Innate Pharma SA 50-day simple moving average is 2.23 while IPHA share price is 2.25, making it a Buy technically.
- IPHA stock price is 2.25 and Innate Pharma SA 200-day simple moving average is 2.46, creating a Sell signal.
IPHA Technical Analysis vs Fundamental Analysis
Sell
16
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy or a Sell?
-
Innate Pharma SA stock is rated a Sell
The current Innate Pharma SA [IPHA] share price is $2.25. The Score for IPHA is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
Innate Pharma SA Stock Info
Market Cap:
182.14M
Price in USD:
2.25
Share Volume:
409
Innate Pharma SA 52-Week Range
52-Week High:
3.15
52-Week Low:
1.81
Sell
16
Innate Pharma SA (IPHA)
is a Sell
Innate Pharma SA Share Price Forecast
-
What is the Innate Pharma SA stock price today?
The Innate Pharma SA stock price is 2.25 USD today. -
Will IPHA stock go up or go down?
Innate Pharma SA> share price is forecast to RISE/FALL based on technical indicators -
Is Innate Pharma SA overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Innate Pharma SA is overvalued.
Is Innate Pharma SA Stock a Buy?
- Innate Pharma SA share price is 2.25 while IPHA 8-day exponential moving average is 2.25, which is a Sell signal.
- The stock price of IPHA is 2.25 while Innate Pharma SA 20-day EMA is 2.26, which makes it a Sell.
- Innate Pharma SA 50-day exponential moving average is 2.26 while IPHA share price is 2.25, making it a Sell technically.
- IPHA stock price is 2.25 and Innate Pharma SA 200-day simple moving average is 2.43, creating a Sell signal.
Fundamental Analysis of Innate Pharma SA
Is Innate Pharma SA a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Innate Pharma SA
Should I short Innate Pharma SA stock?
- IPHA Moving Average Covergence Divergence (MACD) indicator is 0, suggesting Innate Pharma SA is a Buy
- Innate Pharma SA Relative Strength Index (RSI) is 49.51, which suggest Innate Pharma SA is oversold
- The Bollinger Bands (25) for Innate Pharma SA is (2.21 - 2.33), which suggest Innate Pharma SA is a Sell
- The Bollinger Bands (100) for Innate Pharma SA is (2.08 - 2.6), which suggest Innate Pharma SA is a Sell
* Innate Pharma SA stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.